Trial Profile
A Randomized, Controlled, Double-Masked, Multicenter, Exploratory Study of the Clinical Benefit and Safety of OMS302 Injection in Subjects Undergoing Unilateral Cataract Extraction With Lens Replacement (CELR) Using a Coaxial Phacoemulsification Process
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 18 Sep 2014
Price :
$35
*
At a glance
- Drugs Ketorolac/phenylephrine (Primary) ; Mydriatics
- Indications Postoperative pain
- Focus Therapeutic Use
- Sponsors Omeros Corporation
- 09 Feb 2012 New trial record